Modulation of liver function, antioxidant responses, insulin resistance and glucose transport by Oroxylum indicum stem bark in STZ induced diabetic rats

Food and Chemical Toxicology

Volumn 62, Issue , 2013, Pages 722-731

  Singh, Jyotsna ^a   Kakkar, Poonam ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Anti diabetic activity; Antioxidant; BSA glycation; Diabetes mellitus; Insulin sensitivity; Oroxylum indicum (OI)

Indexed keywords

ALPHA GLUCOSIDASE; ANTIDIABETIC AGENT; ANTIOXIDANT; BOVINE SERUM ALBUMIN; CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; GLUCOSE TRANSPORTER 4; GLUTATHIONE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; OROXYLUM INDICUM EXTRACT; PLANT EXTRACT; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BARK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OROXYLUM; OXIDATION; PROTEIN GLYCOSYLATION; PROTEIN TRANSPORT; RAT; SKELETAL MUSCLE; STANDARDIZATION; STREPTOZOCIN DIABETES; TREATMENT DURATION;

OROXYLUM INDICUM; RATTUS;

(4-NPGP); (ABTS); (ADA); (AGE); (AKT/PKB); (ALT); (ANOVA); (AST); (AUC); (BSA); (BUN); (CPCSEA); (DM); (DMEM); (DNPH); (DTNB); (FBG); (FBS); (FITC); (FRAP); (GLUT-4); (GSH); (HB); (HBA1C); (HCT); (HDL); (HOMA-IR); (HRP); (IR); (LDL); (MCV); (MDA); (NA); (OGTT); (OI); (PBS); (PC); (PI3K); (PVDF); (QUICKI); (RBC); (ROS); (RP-HPLC); (SDS-PAGE); (STZ); (TBA); (TC); (TEAC); (TG); (TPTZ); (WBC); (WHO); 2,2′-AZINOBIS (3-ETHYLBENZOTHIAZOLINE-6-SULPHONIC ACID; 2,4,6-TRIPYRIDYL-S-TRIAZINE; 2,4-DINITROPHENYL HYDRAZINE; 4-NITROPHENYL P-D GLUCOPYRANOSIDE; 5,5′DITHIOBIS-2-NITROBENZOIC ACID; ADVANCED GLYCATION END PRODUCTS; ALANINE AMINO TRANSFERASE; AMERICAN DIABETES ASSOCIATION; ANALYSIS OF VARIANCE; ANTI DIABETIC ACTIVITY; ANTIOXIDANT; AREA UNDER THE CURVE; ASPARTATE AMINO TRANSFERASE; BLOOD UREA NITROGEN; BOVINE SERUM ALBUMIN; BSA GLYCATION; COMMITTEE FOR THE PURPOSE OF CONTROL AND SUPERVISION OF EXPERIMENTS ON ANIMALS; DIABETES MELLITUS; DIFFERENTIATION MEDIA; DULBECCO'S MODIFIED EAGLE MEDIUM; FASTING BLOOD GLUCOSE; FERRIC ION REDUCING ANTIOXIDANT POWER; FETAL BOVINE SERUM; FLUORESCEIN ISOTHIOCYANATE; GLUCOSE TRANSPORTER-4; GLYCOSYLATED HEMOGLOBIN; HEAMATOCRIT; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HORSE-RADISH PEROXIDASE; INSULIN RECEPTOR; INSULIN SENSITIVITY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONDIALDEHYDE; MEAN CORPUSCULAR VOLUME; NICOTINAMIDE; ORAL GLUCOSE TOLERANCE TEST; OROXYLUM INDICUM; OROXYLUM INDICUM (OI); PHOSPHATE BUFFER SALINE PH 7.4; PHOSPHATIDYLINOSITOL-3-KINASE; POLYVINYLIDENE DIFLUORIDE; PROTEIN CARBONYLS; PROTEIN KINASE B; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; REACTIVE OXYGEN SPECIES; RED BLOOD CELL COUNTS; REDUCED GLUTATHIONE; REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SODIUM DODECYL SULPHATE-POLYACRYLAMIDE GEL ELECTROPHORESIS; STREPTOZOTOCIN; THIOBARBITURIC ACID; TOTAL CHOLESTEROL; TOTAL GLYCERIDES; TROLOX EQUIVALENT ANTIOXIDANT CAPACITY; WHITE BLOOD CELL COUNTS; WORLD HEALTH ORGANIZATION;

3T3-L1 CELLS; ALPHA-GLUCOSIDASES; ANIMALS; ANTIOXIDANTS; BIGNONIACEAE; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; HYPOGLYCEMIC AGENTS; INDIA; INSULIN RESISTANCE; LIVER; MALE; MICE; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; SERUM ALBUMIN, BOVINE; STREPTOZOCIN;

EID: 84886858307     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.09.035     Document Type: Article

References (48)

1. Ahmadian M., Suh J.M., Hah N., Liddle C., Atkins A.R., Downes M., Evans R.M. PPARγ signaling and metabolism: the good, the bad and the future. Nat. Med. 2013, 2013(19):557-566.
2. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 1996, 239:70-76.
3. Boden G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr. Diab. Rep. 2006, 6:177-181.
4. Bogdanis, G.C., Stavrinou, P., Fatouros, I.G., Philippou, A., Chatzinikolaou, A., Draganidis, D., Ermidis, G., Maridaki, M., 2013. Short-term high-intensity interval exercise training attenuates oxidative stress responses andimproves antioxidant status in healthy humans. Food Chem Toxicol. Jun 6. pii: S0278-6915(13)00352-9. doi:. [Epub ahead of print]. doi:10.1016/j.fct.2013.05.046.
5. Brownlee M. The pathological implications of protein glycation. Clin. Invest. Med. 1995, 18:275-281.
6. Carrizzo A, Forte M, Damato A, Trimarco V, Salzano F, Bartolo M, Maciag A, Puca AA, Vecchione C., 2013. Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases. Food Chem Toxicol. Jul 18. pii: S0278-6915(13)00476-6. doi:. [Epub ahead of print]. doi:10.1016/j.fct.2013.07.021.
7. Chhetri D.R., Parajuli P., Subba G.C. Antidiabetic plants used by Sikkim and Darjeeling Himalayan tribes. India J. Ethnopharmacol. 2005, 99:199-202.
8. Dinda B., Mohanta B.C., Arima S., Sato N., Harigaya Y. Flavonoids from the stem bark of Oroxylum indicum. Nat. Prod. Sci. 2007, 13:190-194.
9. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
10. Goh S.Y., Cooper M.E. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab. 2008, 93:1143-1152.
11. Guasch L., Sala E., Mulero M., Valls C., Salvadó M.J., Pujadas G., Garcia-Vallvé S. Identification of PPAR-gamma partial agonists of natural origin (II): in silico prediction in natural extracts with known antidiabetic activity. PLoS One 2013, 8:e55889. 10.1371/journal.pone.0055889.
12. Hansen J.B., Peterson R.K., Larsen B.M., Bartkova J., Alsner J., Kristiansen K. Activation of peroxisome proliferator-activated receptor bypasses the function of the retinoblastoma protein in adipocyte differentiation. J. Biol. Chem. 1999, 274:2386-2393.
13. Hari Babu T., Manjulatha K., Suresh Kumar G., Hymavathi A., Tiwari A.K., Purohit M., Madhusudana Rao J., Suresh Babu K. Gastroprotective flavonoid constituents from Oroxylum indicum Vent. Bioorg. Med. Chem. Lett. 2010, 20:117-120.
14. Horváth B., Mukhopadhyay P., Haskó G., Pacher P. The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. Am. J. Pathol. 2012, 180:432-442.
15. Jenkins D.J., Taylor R.H., Goff D.V., Fielden H., Misiewicz J.J., Sarson D.L., Bloom S.R., Alberti K.G. Scope and specificity of acarbose in slowing carbohydrate absorption in man. Diabetes 1981, 30:951-954.
16. Joven J., Rull A., Rodriguez-Gallego E., Camps J., Riera-Borrull M., Hernández-Aguilera A., Martin-Paredero V., Segura-Carretero A., Micol V., Alonso-Villaverde C., Menéndez J.A. Multifunctional targets of dietary polyphenols in disease: a case for the chemokine network and energy metabolism. Food Chem. Toxicol. 2013, 51:267-279.
17. Kaldate P., Tenpe C., Yeole P. Antidiabetic activity of leaves of Oroxylum indicum in alloxan-induced diabetic rats. Inventi Rapid: Ethnopharmacol. 2011, 1:468.
18. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., Quon M.J. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrin. Metab. 2000, 85:2402-2410.
19. Klip A., Ramlal T., Bilan P.J., Cartee G.D., Gulve E.A., Holloszy J.O. Recruitment of GLUT-4 glucose transporters by insulin in diabetic rat skeletal muscle. Biochem. Biophys. Res. Commun. 1990, 172:728-736.
20. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., et al. Determination of carbonyl content in oxidatively modified proteins. Meth. Enzymol. 1990, 186:464-478.
21. Liu S.Z., Deng Y.X., Chen B., Zhang X.J., Shi Q.Z., Qiu X.M. Antihyperglycemic effect of the traditional Chinese Scutellaria coptis herb couple and its main components in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 2013, 145:490-498.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
23. Masiello P., Broca C., Gross R., Roye M., Manteghetti M., Hillaire-Buys D., Novelli M., Ribes G. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998, 47:224-229.
24. Matsui T., Ueda T., Sugita K., Terahara N., Matsumoto K. Alpha-glucosidase inhibitors action of natural acylated anthocyanins. Survey of natural pigments with potent inhibitory activity. J. Agric. Food. Chem. 2001, 49:1948-1951.
25. Nedić O., Rattan S.I., Grune T., Trougakos I.P. Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology. Free Radic. Res. 2013, 2013. 10.3109/10715762.2013.806798.
26. Neves D. Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction. Free Radic. Res. 2013, 47:49-69.
27. Nicolle E., Souard F., Faure P., Boumendjel A. Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure-activity relationship. Curr. Med. Chem. 2011, 18:2661-2672.
28. Niki E. Assessment of antioxidant capacity in vitro and in vivo. Free Radic. Biol. Med. 2010, 49:503-515.
29. Prasath G.S., Subramanian S.P. Fisetin, a tetra hydroxy flavone recuperates antioxidant status and protects hepatocellular ultrastructure from hyperglycemia mediated oxidative stress in streptozotocin induced experimental diabetes in rats. Food Chem. Toxicol. 2013, 59:249-255.
30. Puddu A., Viviani G.L. Advanced glycation endproducts and diabetes. Beyond vascular complications. Endocr. Metab. Immune Disord. Drug Targets 2011, 11:132-140.
31. Qu H.Q., Li Q., Rentfro A.R., Fisher-Hoch S.P., McCormick J.B. The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning. Plos One 2011, 6:e21041.
32. Ramasamy R., Yan S.F., Schmidt A.M. The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes. Vascul Pharmacol. 2012, 57:160-167.
33. Re R., Pellegrini N., Proteggente A., Pannala A., Yang M., Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Rad. Biol. Med. 1999, 26:1231-1237.
34. Robertson R.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 2004, 279:42351-42354.
35. Sarafidis P.A., Lasaridis A.N., Nilsson P.M., Pikilidou M.I., Stafilas P.C., Kanaki A., Kazakos K., Yovos J., Bakris G.L. Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes. J. Hum. Hypertens. 2007, 21:709-716.
36. Simm A. Protein glycation during aging and in cardiovascular disease. J. Proteomics 2013, doi: 10.1016/j.jprot.2013.05.012. [Epub ahead of print].
37. Sousa G.T., Lira F.S., Rosa J.C., de Oliveira E.P., Oyama L.M., Santos R.V., Pimentel G.D. Dietary whey protein lessens several risk factors for metabolic diseases: a review. Lipids Health Dis. 2012, 10:11-67.
38. Student A.K., Hsu R.Y., Lane M.D. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J. Biol. Chem. 1980, 255:4745-4750.
39. Subramaniam S.S., Nair A.G. Flavonoids of the stem bark of Oroxylum indicum. Curr. Sci. 1972, 41:62-63.
40. Sunil C., Duraipandiyan V., Agastian P., Ignacimuthu S. Antidiabetic effect of plumbagin isolated from Plumbago zeylanica L. root and its effect on GLUT4 translocation in streptozotocin-induced diabetic rats. Food Chem. Toxicol. 2012, 50:4356-4363.
41. Szkudelski T. Streptozotocin and nicotinamide induced diabetes in the rat. Characteristics of the experimental model. Exp. Biol. Med. 2012, 237:481-490.
42. Tan S., Ng Y., James D.E. Next-generation Akt inhibitors provide greater specificity: effects on glucose metabolism in adipocytes. Biochem. J. 2011, 435:539-544.
43. Tanti J.F., Grillo S., Grémeaux T., Coffer P.J., Van Obberghen E., Le Marchand-Brustel Y. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology 1997, 138:2005-2010.
44. Van Hoek M., Langendonk J.G., de Rooij S.R., Sijbrands E.J.G., Roseboom T.J. Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism. Diabetes 2009, 58:1440-1444.
45. Wallin B., Rosengren B., Shertzer H.G., Camijo G. Lipoprotein oxidation and measurements of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for evaluation of antioxidants. Anal. Biochem. 1993, 208:10-15.
46. Yadav A.K., Manika N., Bagchi G.D., Gupta M.M. Simultaneous determination of flavonoids in Oroxylum indicum by RP-HPLC. Med. Chem. Res. 2013, 22:2222-2227.
47. Yan R.Y., Cao Y.Y., Chen C.Y., Dai H.Q., Yu S.X., Wei J.L., Li H., Yang B. Antioxidant flavonoids from the seed of Oroxylum indicum. Fitoterapia 2011, 82:841-848.
48. Zatalia S.R., Sanusi H. The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus. Acta. Med. Indones. 2013, 45:141-147.